HAAGA, Netherlands – The European Union’s medicines regulator on Thursday authorized the Pfizer coronavirus vaccine for children ages 5-11, paving the way for millions of elementary school students to be vaccinated amid a new wave of infections sweeping across the country. continent.
This is the first time the European Medicines Agency has approved a COVID-19 vaccine for use in young children.
The agency said it “recommended that the indications for the COVID-19 Comirnaty vaccine be expanded to include its use in children aged 5 to 11.”
After evaluating a vaccine study in more than 2,000 children, the EMA evaluated the vaccine’s effectiveness at approximately 90% in preventing symptomatic COVID-19 in young children and stated that the most common side effects were injection site pain, headaches, and muscle aches. pain and chills. The agency said the two-dose regimen should be given to children three weeks apart.
Full story and associated coverage:
At least one country facing skyrocketing infections has not yet received EMA approval. Authorities in the Austrian capital Vienna have already begun vaccinating the 5-11 age group. Europe is currently at the epicenter of a pandemic, and the World Health Organization has warned that 2 million people could die across the continent by spring unless urgent action is taken.
Subscribe now to receive the latest coronavirus headlines and other important local and national news sent to your inbox daily.